SeaStar Medical (ICUCW) Stock Price, News & Analysis

Company Overview

SeaStar Medical, Inc. is a medical device company developing dynamic instrument systems that replicate human wrist motion to enhance dexterity in minimally invasive surgery. The company’s technology provides surgeons with “wristed” articulation capabilities via a mechanically actuated linkage, offering a low-profile and cost-effective alternative to traditional robotic platforms.

SeaStar’s signature instrument platform is designed to integrate with existing laparoscopic trocars, enabling a seamless transition for operating rooms accustomed to conventional laparoscopic equipment. The system is intended to reduce procedural complexity and capital investment without sacrificing the precision and control that robotic platforms traditionally require. In parallel, SeaStar is advancing a complementary port-site management solution aimed at optimizing insufflation stability and camera visualization during keyhole procedures.

Based in the United States, SeaStar Medical is working toward expanding its regulatory clearances and establishing clinical partnerships with hospitals and surgical centers. Guided by a leadership team with deep experience in surgical innovation and medical device development, the company aims to bring next-generation articulation to a broad range of minimally invasive procedures, including general surgery, gynecology and urology.

Key Stats

• Today's Range: $0.0193 to $0.0199
• 50-Day Range: $0.01 to $0.03
• 52-Week Range: $0.01 to $0.08
• Volume: 3,641 shs
• Average Volume: 88,383 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 7/31/2026
• Next Earnings (Estimated): 8/18/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ICUCW
• CIK: 1831868
• Web: www.seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.44 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A